Need anything? Search here.

Rabu, 17 November 2021

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.


By BY REBECCA ROBBINS from NYT Business https://ift.tt/30wUE8X

Tidak ada komentar:

Posting Komentar

Langganan: Posting Komentar (Atom)